Aeglea Biotherapeutics shares owned by Candriam Luxembourg S.C.A.
Quarter-by-quarter ownership of Aeglea Biotherapeutics (SYRE) shares owned by Candriam Luxembourg S.C.A.
from 13F filings
Historical chart of Candriam Luxembourg S.C.A. investment in Aeglea Biotherapeutics
Tip: Access up to 7 years of quarterly data
All positions including Aeglea Biotherapeutics held by Candriam Luxembourg S.C.A. consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Aeglea Biotherapeutics by Candriam Luxembourg S.C.A.
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $6.8M | 404k | 16.76 |
| 2025-06-30 | $3.7M | 246k | 14.97 |
| 2025-03-31 | $4.0M | 246k | 16.14 |
| 2024-12-31 | $5.8M | 248k | 23.28 |
| 2024-09-30 | $3.1M | 105k | 29.41 |
| 2024-06-30 | $2.5M | 105k | 23.51 |
| 2024-03-31 | $4.0M | 105k | 37.93 |
More positions owned by Candriam Luxembourg S.C.A.
View all positions for Candriam Luxembourg S.C.A.